Systematic Review and Meta-Analysis of SERPINE1 4G/5G Insertion/Deletion Variant With Circulating Lipid Levels

Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD....

Full description

Saved in:
Bibliographic Details
Published inFrontiers in cardiovascular medicine Vol. 9; p. 859979
Main Authors Luo, Zhi, Liu, Yang, Li, Hang, Zhou, Yawen, Peng, Yuanyuan, Lin, Xuan, Fang, Ying, Wan, Jing, Wei, Baozhu
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 23.06.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.By searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.Methods and ResultsBy searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.The rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.ConclusionThe rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.
AbstractList BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.Methods and ResultsBy searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = –0.12, 95% CI = –0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = –0.12, 95% CI = –0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = –0.13, 95% CI = –0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = –0.15, 95% CI = –0.26 to 0.05, P < 0.01) and TC (SMD = –0.17, 95% CI = –0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03–0.48, P = 0.03) levels was detected only in female subjects.ConclusionThe rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.
Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims to clarify the effects of the rs1799889 variant on lipid levels and to insight into the mechanisms underlying the rs1799889 variant and CAD.By searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.Methods and ResultsBy searching PubMed and the Cochrane databases for studies published before 31 October 2021, 40 studies conducted on a total of 13,117 subjects were included for the analysis. The consistent findings for the effects of the 5G allele of rs1799889 variant on lipid metabolism were the significantly decreased triglycerides (TG) [standardized mean difference (SMD) = -0.12, 95% CI = -0.21 to 0.03, P = 0.01], total cholesterol (TC) (SMD = -0.12, 95% CI = -0.17 to 0.06, P < 0.001), and low-density lipoprotein cholesterol (LDL-C) (SMD = -0.13, 95% CI = -0.23 to 0.03, P = 0.01) levels. Intriguingly, the significant effects of the rs1799889 variant on LDL-C (SMD = -0.15, 95% CI = -0.26 to 0.05, P < 0.01) and TC (SMD = -0.17, 95% CI = -0.27 to 0.07, P < 0.01) levels were primarily observed in the Asian population. However, the significant effect of the rs1799889 variant on high-density lipoprotein cholesterol (HDL-C) (SMD = 0.26, 95% CI = 0.03-0.48, P = 0.03) levels was detected only in female subjects.The rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.ConclusionThe rs1799889 variant of SERPINE1 is a protective genetic factor against CAD, the Asian population with the 5G allele of the rs1799889 variant may have a reduced CAD risk.
Author Peng, Yuanyuan
Li, Hang
Zhou, Yawen
Lin, Xuan
Luo, Zhi
Fang, Ying
Liu, Yang
Wan, Jing
Wei, Baozhu
AuthorAffiliation 1 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China
3 Department of Geratology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China
4 Institute of Myocardial Injury and Repair, Wuhan University , Wuhan , China
2 Department of Endocrinology, China Resources and WISCO General Hospital , Wuhan , China
AuthorAffiliation_xml – name: 2 Department of Endocrinology, China Resources and WISCO General Hospital , Wuhan , China
– name: 4 Institute of Myocardial Injury and Repair, Wuhan University , Wuhan , China
– name: 1 Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China
– name: 3 Department of Geratology, Zhongnan Hospital of Wuhan University, Wuhan University , Wuhan , China
Author_xml – sequence: 1
  givenname: Zhi
  surname: Luo
  fullname: Luo, Zhi
– sequence: 2
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
– sequence: 3
  givenname: Hang
  surname: Li
  fullname: Li, Hang
– sequence: 4
  givenname: Yawen
  surname: Zhou
  fullname: Zhou, Yawen
– sequence: 5
  givenname: Yuanyuan
  surname: Peng
  fullname: Peng, Yuanyuan
– sequence: 6
  givenname: Xuan
  surname: Lin
  fullname: Lin, Xuan
– sequence: 7
  givenname: Ying
  surname: Fang
  fullname: Fang, Ying
– sequence: 8
  givenname: Jing
  surname: Wan
  fullname: Wan, Jing
– sequence: 9
  givenname: Baozhu
  surname: Wei
  fullname: Wei, Baozhu
BookMark eNp1kU1vEzEQhi1UREvpnaOPXDaxvWuvfUGqQgiRwodavm6W1zubuvLawd4E5d-zS4pEkTjNaGbeZ0bzPkdnIQZA6CUls7KUat7ZQz9jhLGZ5ErV6gm6YEzVBeH8-9lf-Tm6yvmeEEJ5JbmQz9B5ySWlNSUXKNwe8wC9GZzFN3Bw8BOb0OL3MJjiOhh_zC7j2OHb5c2n9YclxdVqzld4HTKkwcUwfwMepgR_NcmZMOBvbrjDC5fs3o_UsMUbt3Mt3sABfH6BnnbGZ7h6iJfoy9vl58W7YvNxtV5cbwpblWooGguWdURSYhRXQijGm5JZA1XbKVC0JqU13DLoGAepJJfEtlQqoxrLoWnLS7Q-cdto7vUuud6ko47G6d-FmLbajPdbD7prBIxrRFNyqGrBDGPc1lJU3fQyQUbW6xNrt296aC2EIRn_CPq4E9yd3saDVkwQSsoR8OoBkOKPPeRB9y5b8N4EiPusmZCSSMElG0fFadSmmHOCTls3mOm_I9l5TYmevNeT93ryXp-8H4XkH-Gf-_4r-QWnprM8
CitedBy_id crossref_primary_10_1002_advs_202412578
crossref_primary_10_3390_genes16020223
crossref_primary_10_1016_j_heliyon_2024_e35426
crossref_primary_10_1371_journal_pone_0317511
Cites_doi 10.1248/bpb.b20-00321
10.3390/ijms19041197
10.1038/s41598-020-79948-x
10.1007/s00063-006-1090-0
10.1515/cclm-2013-1124
10.1016/j.thromres.2012.06.015
10.3164/jcbn.11-48
10.1161/circ.106.25.3143
10.14712/fb2020066050169
10.1371/journal.pone.0033511
10.2337/db12-1552
10.1210/en.2013-1888
10.1081/erc-200035728
10.1038/sj.emboj.7601082
10.1093/eurheartj/ehz455
10.1074/jbc.273.11.6358
10.1016/0925-4773(96)00515-1
10.1161/01.atv.11.1.183
10.3389/fgene.2021.746686
10.1182/blood.V92.9.3277
10.1016/j.jclinepi.2009.06.006
10.1007/s11239-009-0398-z
10.1007/s00508-005-0425-9
10.1080/21623945.2020.1748961
10.1371/journal.pone.0079150
10.1073/pnas.92.6.1851
ContentType Journal Article
Copyright Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei.
Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei. 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei
Copyright_xml – notice: Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei.
– notice: Copyright © 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei. 2022 Luo, Liu, Li, Zhou, Peng, Lin, Fang, Wan and Wei
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fcvm.2022.859979
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2297-055X
ExternalDocumentID oai_doaj_org_article_fb6e0a96b35e4762a225c7864f000160
PMC9260103
10_3389_fcvm_2022_859979
GroupedDBID 53G
5VS
9T4
AAFWJ
AAYXX
ACGFS
ACXDI
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
CITATION
GROUPED_DOAJ
HYE
KQ8
M48
M~E
OK1
PGMZT
RPM
7X8
5PM
ID FETCH-LOGICAL-c439t-bcec2f0810a95966925b32cae4df9e91703ca5c2ef25e898580cd189a9bc5ebd3
IEDL.DBID M48
ISSN 2297-055X
IngestDate Wed Aug 27 01:10:44 EDT 2025
Thu Aug 21 18:08:21 EDT 2025
Fri Jul 11 09:35:53 EDT 2025
Thu Apr 24 22:57:52 EDT 2025
Tue Jul 01 01:10:16 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c439t-bcec2f0810a95966925b32cae4df9e91703ca5c2ef25e898580cd189a9bc5ebd3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
Edited by: Neil Morgan, University of Birmingham, United Kingdom
Reviewed by: Guangyu Zhang, City of Hope National Medical Center, United States; Yingfeng Wan, University of Michigan, United States
These authors have contributed equally to this work and share first authorship
This article was submitted to Cardiovascular Genetics and Systems Medicine, a section of the journal Frontiers in Cardiovascular Medicine
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fcvm.2022.859979
PMID 35811710
PQID 2688086582
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_fb6e0a96b35e4762a225c7864f000160
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9260103
proquest_miscellaneous_2688086582
crossref_citationtrail_10_3389_fcvm_2022_859979
crossref_primary_10_3389_fcvm_2022_859979
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-06-23
PublicationDateYYYYMMDD 2022-06-23
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-23
  day: 23
PublicationDecade 2020
PublicationTitle Frontiers in cardiovascular medicine
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Tamura (B4) 2014; 155
Vash (B23) 1998; 92
Botta (B21) 2018; 19
Liu (B5) 2020; 9
Li (B29) 2012; 7
Cao (B24) 2006; 25
Rallidis (B16) 2010; 29
Tamura (B3) 2013; 62
Liu (B12) 2021; 12
Liberati (B11) 2009; 62
Xu (B10) 2013; 8
Stefansson (B22) 1998; 273
Eriksson (B2) 1995; 92
Liang (B9) 2015; 8
Funk (B13) 2005; 117
(B28) 2002; 106
Grundy (B26) 2019; 139
de la Cruz-Mosso (B17) 2016; 57
Mach (B27) 2020; 41
Yoda (B20) 2020; 43
Zietz (B19) 2006; 101
Gong (B8) 2012; 130
Zietz (B18) 2004; 30
Teesalu (B25) 1996; 56
Levine (B6) 2021; 11
Dawson (B1) 1991; 11
Nikolopoulos (B7) 2014; 52
Mahmutbegovic (B14) 2020; 66
Al-Hamodi (B15) 2012; 50
References_xml – volume: 57
  start-page: 246
  year: 2016
  ident: B17
  article-title: PAI-1 haplogenotype confers genetic susceptibility for obesity and hypertriglyceridemia in Mexican children.
  publication-title: Invest Clin.
– volume: 43
  start-page: 1375
  year: 2020
  ident: B20
  article-title: Gene Deletion of calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) suppresses adipogenic differentiation of mouse embryonic fibroblasts.
  publication-title: Biol Pharm Bull.
  doi: 10.1248/bpb.b20-00321
– volume: 19
  year: 2018
  ident: B21
  article-title: PPAR agonists and metabolic syndrome: an established role?
  publication-title: Int J Mol Sci.
  doi: 10.3390/ijms19041197
– volume: 11
  year: 2021
  ident: B6
  article-title: Role of PAI-1 in hepatic steatosis and dyslipidemia.
  publication-title: Sci Rep.
  doi: 10.1038/s41598-020-79948-x
– volume: 101
  start-page: 605
  year: 2006
  ident: B19
  article-title: Kandidatengene des diabetes mellitus typ 2 Gibt es einen Gen-Dosiseffekt für Risikofaktoren sowie mikro-und makrovaskuläre Folgeerkrankungen?
  publication-title: Med Klin (Munich).
  doi: 10.1007/s00063-006-1090-0
– volume: 52
  start-page: 937
  year: 2014
  ident: B7
  article-title: The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
  publication-title: Clin Chem Lab Med.
  doi: 10.1515/cclm-2013-1124
– volume: 139
  start-page: e1082
  year: 2019
  ident: B26
  article-title: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology/American heart association task force on clinical practice guidelines.
  publication-title: Circulation.
– volume: 130
  start-page: e43
  year: 2012
  ident: B8
  article-title: Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis.
  publication-title: Thromb Res.
  doi: 10.1016/j.thromres.2012.06.015
– volume: 50
  start-page: 184
  year: 2012
  ident: B15
  article-title: Plasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects.
  publication-title: J Clin Biochem Nutr.
  doi: 10.3164/jcbn.11-48
– volume: 106
  start-page: 3143
  year: 2002
  ident: B28
  article-title: Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report.
  publication-title: Circulation.
  doi: 10.1161/circ.106.25.3143
– volume: 66
  start-page: 169
  year: 2020
  ident: B14
  article-title: Bosnian study on markers of ischaemic stroke in adults 20-50 years old (SMISAO): preliminary report.
  publication-title: Folia Biol (Praha).
  doi: 10.14712/fb2020066050169
– volume: 7
  year: 2012
  ident: B29
  article-title: Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0033511
– volume: 62
  start-page: 3170
  year: 2013
  ident: B3
  article-title: Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice.
  publication-title: Diabetes.
  doi: 10.2337/db12-1552
– volume: 155
  start-page: 1708
  year: 2014
  ident: B4
  article-title: Plasminogen activator inhibitor-1 deficiency ameliorates insulin resistance and hyperlipidemia but not bone loss in obese female mice.
  publication-title: Endocrinology.
  doi: 10.1210/en.2013-1888
– volume: 30
  start-page: 443
  year: 2004
  ident: B18
  article-title: Allelic frequency of the PAI-1 4G/5G promoter polymorphism in patients with type 2 diabetes mellitus and lack of association with PAI-1 plasma levels.
  publication-title: Endocr Res.
  doi: 10.1081/erc-200035728
– volume: 25
  start-page: 1860
  year: 2006
  ident: B24
  article-title: Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration.
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7601082
– volume: 41
  start-page: 111
  year: 2020
  ident: B27
  article-title: 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
  publication-title: Eur Heart J.
  doi: 10.1093/eurheartj/ehz455
– volume: 273
  start-page: 6358
  year: 1998
  ident: B22
  article-title: Plasminogen activator inhibitor-1 contains a cryptic high affinity binding site for the low density lipoprotein receptor-related protein.
  publication-title: J Biol Chem.
  doi: 10.1074/jbc.273.11.6358
– volume: 56
  start-page: 103
  year: 1996
  ident: B25
  article-title: Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of uPA, uPAR, PAI-1 and alpha 2MR/LRP genes.
  publication-title: Mech Dev.
  doi: 10.1016/0925-4773(96)00515-1
– volume: 11
  start-page: 183
  year: 1991
  ident: B1
  article-title: Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.
  publication-title: Arterioscler Thromb.
  doi: 10.1161/01.atv.11.1.183
– volume: 8
  start-page: 2097
  year: 2015
  ident: B9
  article-title: PAI-1 4G/5G polymorphism and coronary artery disease risk: a meta-analysis.
  publication-title: Int J Clin Exp Med.
– volume: 12
  year: 2021
  ident: B12
  article-title: Associations of the miRNA-146a rs2910164 and the miRNA-499a rs3746444 polymorphisms with plasma lipid levels: a meta-analysis.
  publication-title: Front Genet.
  doi: 10.3389/fgene.2021.746686
– volume: 92
  start-page: 3277
  year: 1998
  ident: B23
  article-title: Three complement-type repeats of the low-density lipoprotein receptor-related protein define a common binding site for RAP, PAI-1, and lactoferrin.
  publication-title: Blood.
  doi: 10.1182/blood.V92.9.3277
– volume: 62
  start-page: e1
  year: 2009
  ident: B11
  article-title: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
  publication-title: J Clin Epidemiol.
  doi: 10.1016/j.jclinepi.2009.06.006
– volume: 29
  start-page: 497
  year: 2010
  ident: B16
  article-title: Reduced carriership of 4G allele of plasminogen activator inhibitor-1 4G/5G polymorphism in very young survivors of myocardial infarction.
  publication-title: J Thromb Thrombolysis.
  doi: 10.1007/s11239-009-0398-z
– volume: 117
  start-page: 707
  year: 2005
  ident: B13
  article-title: PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
  publication-title: Wien Klin Wochenschr.
  doi: 10.1007/s00508-005-0425-9
– volume: 9
  start-page: 170
  year: 2020
  ident: B5
  article-title: Transplantation of adipose tissue lacking PAI-1 improves glucose tolerance and attenuates cardiac metabolic abnormalities in high-fat diet-induced obesity.
  publication-title: Adipocyte.
  doi: 10.1080/21623945.2020.1748961
– volume: 8
  year: 2013
  ident: B10
  article-title: PAI-1 -675 4G/5G polymorphism in association with diabetes and diabetic complications susceptibility: a meta-analysis study.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0079150
– volume: 92
  start-page: 1851
  year: 1995
  ident: B2
  article-title: Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.
  publication-title: Proc Natl Acad Sci USA.
  doi: 10.1073/pnas.92.6.1851
SSID ssj0001548568
Score 2.2351167
SecondaryResourceType review_article
Snippet Recent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This study aims...
BackgroundRecent studies have shown that the 4G/5G insertion/deletion variant of SERPINE1 (rs1799889) is closely linked to coronary artery disease (CAD). This...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 859979
SubjectTerms Asian
Cardiovascular Medicine
coronary artery disease
lipid
polymorphism
rs1799889
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Rb9MwELbQHiZeEAwQhYE8iRceQlo7TuxH2LoVRHlgDPpmOWd7q4Tcqc32-7lL0qp5YS88RUocJb475-7Lnb9j7D34qlAQZSahihlRnmcm-oALzztQiD_CmPYOz7-Xs6vi60It9lp9UU1YRw_cCS6PNQ03ZS1VKHDlOjRAqHRZxDZcadE6-rw9MNXtDy60KnWXl0QUZvII97TxXIiPWhlDlVt7fqil6x_EmMMKyT2Xc_6UPeljRf6pe8dn7FFIR-xw3mfDn7N0uaNh5t0_fu6S5_PQuGxLNsJXkV9OfyB4n054cZGrC_4lUQYe9ZGfBaLeXiX-CxEzipj_XjY3_HS5hrapV7rm1Nra829UWbR5wa7Opz9PZ1nfPyEDDDOarIYAIqLPR_kphDVGqFoKcKHw0QTEaWMJToEIUaigjVZ6DH6ijTM1qFB7-ZIdpFUKrxivXKzaaKXyvgB0YW4ig8dYEuNNPPgRy7fStNCTi1OPiz8WQQbJ35L8LcnfdvIfsQ-7O247Yo1_jP1MCtqNI0rs9gQaiu0NxT5kKCN2slWvxSVEeRGXwupuY0WJHzGNkxMjVg30Pnji8Epa3rRk3IY42cby9f94xTfsMc2aKtGEPGYHzfouvMWYp6nfteb9F3yR_x4
  priority: 102
  providerName: Directory of Open Access Journals
Title Systematic Review and Meta-Analysis of SERPINE1 4G/5G Insertion/Deletion Variant With Circulating Lipid Levels
URI https://www.proquest.com/docview/2688086582
https://pubmed.ncbi.nlm.nih.gov/PMC9260103
https://doaj.org/article/fb6e0a96b35e4762a225c7864f000160
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZpAqWX0ifdvFChlx6c9UrWyjqEkqabR-n20HTbvQlZj2QhyM2uU5p_nxnbu40hhJwMfshoxqP5xqP5hpAP1slM2MATbmVIkPI8UcF5MDxnrID4w6dYOzz-PjyZZF-nYvq_PLoV4OLe0A77SU3ml3v_rm4-gcHvY8QJ_rYf7F-sKWdsLxdKSfWEbIBfkmim4xbsNzXDWd7UxjGGFKRCTJu85b2DdPxUTeffwaDdHZR3XNLRC_K8xZL0oFH-S7Lm4yvydNxmy1-TeLaiaaZNDoCa6OjYVyZZkpHQMtCz0Q8I7kcDmh33xTE9jZihB331v3ik5i4j_QURNaiA_p5VF_RwNrd10694TrH1taPfcOfR4g2ZHI1-Hp4kbX-FxAIMqZLCessCYILUKAFhj2Ki4Mwan7mgPMRxKbdGWOYDEz5XuchT6wa5MqqwwheOvyXrsYz-HaHSBFmjGelcZsHFmQH3DrAm4FE4uB7pL6WpbUs-jj0wLjUEISh_jfLXKH_dyL9HPq6e-NMQbzxw72dU0Oo-pMyuT5Tzc91aoA4FfndqWHDhM3ABBlYyK_NhFmrcm_bI-6V6NZgY5k1M9OX1QrMhLHI5TI71iOzovfPG7pU4u6jJuhVytqV88xGjb5FnOCnciMb4Nlmv5td-ByBPVezWvwp26-_5Fo2MAFs
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systematic+Review+and+Meta-Analysis+of+SERPINE1+4G%2F5G+Insertion%2FDeletion+Variant+With+Circulating+Lipid+Levels&rft.jtitle=Frontiers+in+cardiovascular+medicine&rft.au=Luo%2C+Zhi&rft.au=Liu%2C+Yang&rft.au=Li%2C+Hang&rft.au=Zhou%2C+Yawen&rft.date=2022-06-23&rft.issn=2297-055X&rft.eissn=2297-055X&rft.volume=9&rft.spage=859979&rft_id=info:doi/10.3389%2Ffcvm.2022.859979&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2297-055X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2297-055X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2297-055X&client=summon